Ian Kantrowitz - 22 Feb 2024 Form 4 Insider Report for ALPINE 4 HOLDINGS, INC.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
26 Feb 2024, 18:13:44 UTC
Prior SEC filing
30 Dec 2021
Next SEC filing
11 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/S/ IAN KANTROWITZ

Key filing fact

Ian Kantrowitz filed Form 4 for ALPINE 4 HOLDINGS, INC. on 26 Feb 2024.

Key facts

  • This page summarizes Ian Kantrowitz's Form 4 filing for ALPINE 4 HOLDINGS, INC..
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 26 Feb 2024, 18:13.

Change

  • Previous filing in this sequence was filed on 30 Dec 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALPP transaction Derivative

EMPLOYEE STOCK OPTION (RIGHT TO BUY)

Award

Transaction value
$0
Shares
+550,000
Change %
Price
$0.000000
Shares after
550,000
Date
22 Feb 2024
Ownership
Direct
Underlying class
CLASS A COMMON STOCK
Underlying amount
550,000
Exercise price
$0.6990
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

THE OPTION VESTS AS FOLLOWS: 165,000 OPTIONS VEST ON THE FIRST ANNIVERSARY OF THE GRANT DATE; 165,000 VEST ON THE SECOND ANNIVERSARY OF THE GRANT DATE; AND 220,000 OPTIONS VEST ON THE THIRD ANNIVERSARY OF THE GRANT DATE.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .